Datasets mainly consist of ambiguous objects, redundant and uncertain attribute values which increase complexity, time and cost in Knowledge Discovery in Databases (KDD) process. Rough set-based attribute reduction techniques deals with ambiguity but fails to handle uncertainty available in a real-valued dataset. Combining rough set with intuitionistic fuzzy set provides a great opportunity to the researchers working on attribute reduction of real-valued datasets as it provides better results when compared to the traditional fuzzy rough set theory. In this paper, we present a new intuitionistic fuzzy rough set model for attribute reduction to avoid misclassification and perturbation by handling hesitancy, ambiguity and uncertainty present in a dataset. We define an intuitionistic fuzzy tolerance relation between two objects along with lower and upper approximations based on that relation. Next, the concept of Degree of dependency is utilized to present attribute reduction by using model due to its better performing nature over other methods. The algorithm of the proposed technique is applied on benchmark datasets to perform a comparative study with recent approaches. We obtain the best result for the reduced Breast Cancer dataset by our proposed approach, with an accuracy of 98.96% along with 0.90 standard deviation by using SMO classifier. Finally, our proposed method is used to present a methodology to improve the prediction of umami peptides. Here, we record the best results with sensitivity, specificity, accuracy, AUC, and MCC of 96.8%, 93.6%, 97.7%, 0.988, and 0.899, respectively. From the experiments, it can be concluded that our method outperforms the existing methods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.